Global Ophthalmic Eye Dropper Market
Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 Billion Opportunity by 2034 with Regional and Country-Level Data for Types, Drugs, Treatments, and End-users
March 12, 2024 12:13 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region" report has been added to ...
Transparency Market Research
Glaucoma Treatment Market Set to Surge at 4.3% CAGR, to Reach USD 9.1 billion by 2031 | Transparency Market Research, Inc.
December 19, 2023 03:41 ET | Transparency Market Research
Wilmington, Delaware, United States, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The glaucoma treatment market was valued at US$ 6.3 billion in 2022. A CAGR of 4.3% is...
22157.jpg
Ocular Hypertension Pipeline Research Report 2023: Comprehensive Insights About 70+ Companies and 75+ Pipeline Drugs
November 24, 2023 05:43 ET | Research and Markets
Dublin, Nov. 24, 2023 (GLOBE NEWSWIRE) -- The "Ocular Hypertension - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Ocular Hypertension - Pipeline...
Global Glaucoma Treatment Market
Prostaglandin Analogs Dominating Global Glaucoma Treatment Market - Ongoing Technological Advancements Boost Growth
August 03, 2023 07:48 ET | Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Glaucoma Treatment Market by Indication, Type, Sales Channel - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering. ...
Growth Plus Reports Logo.jpg
Glaucoma Treatment Market Report (2023 to 2031) – Alcon, Merck & Co., Inc., Novartis AG, Pfizer Inc., and AbbVie Inc.
June 13, 2023 09:30 ET | Growth Plus Reports
Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glaucoma treatment market was conducted by Growth Plus Reports in 2022 and is valued at US$ 5.89 billion....
22157.jpg
Global Glaucoma Treatment Market Report 2022: Continuous Drug Innovations Presents Opportunities
September 20, 2022 05:18 ET | Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Glaucoma treatment Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global glaucoma...
22157.jpg
Global Glaucoma Markets and Competitive Landscape Report 2021-2026
September 10, 2021 03:33 ET | Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Glaucoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Global Glaucoma Market and...
22157.jpg
Europe Glaucoma Market and Competitive Landscape Report 2021-2026
September 10, 2021 02:58 ET | Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Europe Glaucoma Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe Glaucoma Market and...
22157.jpg
Global Antiglaucoma Drugs Market Report 2020-2030: Top 8 Competitors Account for 44% of the Total Market in 2019 - Major Players are Allergen, Novartis, Santen Pharmaceuticals, Akorn and Pfizer
February 03, 2021 05:33 ET | Research and Markets
Dublin, Feb. 03, 2021 (GLOBE NEWSWIRE) -- The "Antiglaucoma Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Rockland Eye Physicians and Surgeons Logo
Rockland Eye Physicians & Surgeons Welcomes New Optometrist
July 02, 2013 12:30 ET | Rockland Eye Physicians and Surgeons
ROCKLAND, NY, July 2, 2013 (GLOBE NEWSWIRE) -- Comprehensive New York ophthalmology practice, Rockland Eye Physicians & Surgeons, announces the arrival of Rockland County optometrist, Dr. Matthew...